Sustained Delivery of a Monoclonal Antibody against SARS-CoV-2 by Microencapsulated Cells: A Proof-of-Concept Study

Background: Monoclonal antibody (mAb) therapy is a promising antiviral intervention for Coronovirus disease (COVID-19) with a potential for both treatment and prophylaxis. However, a major barrier to implementing mAb therapies in clinical practice is the intricate nature of mAb preparation and deliv...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashimova, Assem, Myngbay, Askhat, Yegorov, Sergey, Negmetzhanov, Baurzhan, Kadyrova, Irina, Yershova, Angelina, Kart, Ulpan, Miller, Matthew S., Hortelano, Gonzalo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607555/
https://www.ncbi.nlm.nih.gov/pubmed/36297477
http://dx.doi.org/10.3390/pharmaceutics14102042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607555/
https://www.ncbi.nlm.nih.gov/pubmed/36297477
http://dx.doi.org/10.3390/pharmaceutics14102042

Ejemplares similares